EE680 Axicabtagene Ciloleucel as Second-Line Treatment for Relapsed/Refractory Large B-Cell Lymphoma in Spain: A Cost-Effectiveness Analysis
Abstract
Authors
V. Ortiz-Maldonado M. Presa N. Tejado C. Pardo Millan V. Martín-Escudero I. Oyagüez A. Martín García-Sancho